China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A non-invasive biomarker model for dynamic monitoring and assessment of the risk of disease progression in Epstein-Barr virus (EBV)-related diseases'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129842

Registration Time: 2026/08/11

Type: Diagnostic test

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337638

Published by HT Digital Content Services with permission from Health Daily Digest....